Seretide 50+250 mikrog./dosis inhalationspulver, afdelt Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

seretide 50+250 mikrog./dosis inhalationspulver, afdelt

glaxosmithkline pharma a/s - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+250 mikrog./dosis

Dasatinib Accord Den Europæiske Union - dansk - EMA (European Medicines Agency)

dasatinib accord

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiske midler - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.

Dasatinib Accordpharma Den Europæiske Union - dansk - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiske midler - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Dexanova 1 mg/ml øjendråber, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

dexanova 1 mg/ml øjendråber, opløsning

pharmaselect international beteiligungs gmbh - dexamethasonnatriumphosphat - øjendråber, opløsning - 1 mg/ml